share_log

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Mar 5 06:54
Summary by Futu AI
Arcutis Biotherapeutics, Inc. officer Todd Franklin Watanabe is set to sell 14,903 shares of common stock on 03/04/2024, with an aggregate market value of $165,739. The shares to be sold were recently acquired through restricted stock vesting on 03/01/2024 and 03/03/2024, totaling 14,903 shares. This transaction follows a recent sale of 2,465 shares by Watanabe on 02/28/2024, which grossed $26,129.
Arcutis Biotherapeutics, Inc. officer Todd Franklin Watanabe is set to sell 14,903 shares of common stock on 03/04/2024, with an aggregate market value of $165,739. The shares to be sold were recently acquired through restricted stock vesting on 03/01/2024 and 03/03/2024, totaling 14,903 shares. This transaction follows a recent sale of 2,465 shares by Watanabe on 02/28/2024, which grossed $26,129.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.